EC approves GSK’s Jemperli-chemo combo for endometrial cancer
The European Commission (EC) has approved GSK's Jemperli (dostarlimab) combined with chemotherapy that includes carboplatin and paclitaxel for the first-line …
The European Commission (EC) has approved GSK's Jemperli (dostarlimab) combined with chemotherapy that includes carboplatin and paclitaxel for the first-line …
Moderna is set to receive $590m in funding from the US Department of Health and Human Services (HHS) to expedite …
Investment company RTW Investments has launched a new biotech company called Prolium Bioscience, to advance the development of ICP-B02, a …
This week, at the J.P. Morgan Healthcare Conference and the Biotech Showcase, discussions underscored the growing focus on innovation in …
As companies across the pharma and biotech sectors gathered at the annual JPM Healthcare Conference 2025, held from 13 January …
Leading account and intent-based sales and marketing providers and technology solutions for the pharmaceutical industry: Introduction In the vast global landscape …
The US Food and Drug Administration (FDA) has accepted a new drug application (NDA) for Arrowhead Pharmaceutical’s plozasiran in the …
AstraZeneca has received approval from the US Food and Drug Administration (FDA) for its Bruton’s tyrosine kinase (BTK) inhibitor, Calquence …
Northwell Health’s Feinstein Institutes for Medical Research has received a five-year, $2.9m grant from the National Institutes of Health (NIH) …
Leading sales and marketing intent data, database and data enrichment providers and technology solutions for the pharmaceutical industry: introduction In the …
Amgen’s LUMAKRAS (sotorasib) and Vectibix (panitumumab) combination has received approval from the US Food and Drug Administration (FDA) to treat …
Approaching his 200th day as the new Chief Executive Officer of Lonza, Wolfgang Wienand discussed the company’s plans to exit …
Shionogi has been awarded $375m by the US Department of Health and Human Services (HHS) to develop a long-acting therapeutic …
IMPACT Therapeutics has received the China National Medical Products Administration (NMPA) marketing authorisation for Senaparib capsules to treat ovarian cancer. The …
The US government has unveiled 15 additional drugs that will be covered in the next round of Medicare Part D …